Parsons Capital Management’s Neuraxis NRXS Stock Holding History

Parsons Capital Management’s Portfolio NRXS Stock Details NRXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$861K	Buy	117,808 +1,082	+0.9%	+$7.98K	0.04%	307
2026 Q1	$864K	Hold	116,726	–	–	0.04%	287
2025 Q4	$530K	Hold	116,726	–	–	0.03%	319
2025 Q3	$360K	Hold	116,726	–	–	0.02%	360
2025 Q2	$282K	Hold	116,726	–	–	0.02%	383
2025 Q1	$251K	Hold	116,726	–	–	0.01%	388
2024 Q4	$274K	Buy	116,726 +103,726	+798%	+$291K	0.01%	389
2024 Q3	$38.7K	Hold	13,000	–	–	﹤0.01%	442
2024 Q2	$36.1K	Hold	13,000	–	–	﹤0.01%	436
2024 Q1	$40.6K	Hold	13,000	–	–	﹤0.01%	435
2023 Q4	$34.7K	Buy	+13,000	New	+$35.2K	﹤0.01%	428

Other funds holding NRXS

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

UIA

Ulland Investment Advisors Minneapolis, Minnesota $136M AUM 32.68% 1-Year Est. Return

Parsons Capital Management's NRXS Position: Q2 2026 in Review

Parsons Capital Management increased its Neuraxis (NRXS) stake by 0.93% in Q2 2026, buying an estimated $7.98K and bringing the position to 117,808 shares worth $861K. The position accounts for 0.04% of the portfolio, ranked #307.

Parsons Capital Management first reported a position in NRXS in Q4 2023 and has held it in 11 quarters since. The position peaked at $864K in Q1 2026. 3 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

Parsons Capital Management held 117,808 shares of Neuraxis worth $861K as of Q2 2026.
Parsons Capital Management bought 1,082 Neuraxis shares in Q2 2026, an estimated $7.98K.
Neuraxis made up 0.04% of Parsons Capital Management's portfolio in Q2 2026, its #307 holding.
Parsons Capital Management first reported a position in Neuraxis in Q4 2023 and has held it in 11 quarters since.
Parsons Capital Management's Neuraxis position peaked at $864K in Q1 2026.
3 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Parsons Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.